Showing results (91-100 of 100) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Pediatric Dermatology|November 28, 2020
Characterization of wound microbes in epidermolysis bullosa: Results from the epidermolysis bullosa clinical characterization and outcomes databaseLaura E Levin, Leila H Shayegan, Anne W Lucky, et al.JAMA Dermatology|December 12, 2019
Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE SyndromeGerilyn M Olsen, Leanna M Hansen, Nicole S Stefanko, et al.JAMA Dermatology|December 27, 2018
Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North AmericaJames A Feinstein, Purevsuren Jambal, Kathleen Peoples, et al.The Journal of Investigative Dermatology|November 28, 2017
Analyzing the Genetic Spectrum of Vascular Anomalies with Overgrowth via Cancer GenomicsDawn H Siegel, Catherine E Cottrell, Jenna L Streicher, et al.Pediatric Dermatology|April 17, 2020
Management of infantile hemangiomas during the COVID pandemicIlona J Frieden, Katherine B Püttgen, Beth A Drolet, et al.Journal of the American Academy of Dermatology|October 11, 2021
A retrospective analysis of diagnostic testing in a large North American cohort of patients with epidermolysis bullosaGregory Scott Phillips, Amy Huang, Bret D Augsburger, et al.Journal of the American Academy of Dermatology|April 15, 2020
Limited utility of repeated vital sign monitoring during initiation of oral propranolol for complicated infantile hemangiomaKatherine B Püttgen, Leanna M Hansen, Christine Lauren, et al.The Journal of Pediatrics|January 13, 2024
Multicenter Study of Long-Term Outcomes and Quality of Life in PHACE Syndrome after Age 10Mitchell Braun, Ilona J Frieden, Dawn H Siegel, et al.The New England Journal of Medicine|February 19, 2015
A randomized, controlled trial of oral propranolol in infantile hemangiomaChristine Léauté-Labrèze, Peter Hoeger, Juliette Mazereeuw-Hautier, et al.The Journal of Infection|June 5, 2026
Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trialRosie Harris, Russell Thirard, Claire McBrien, et al.Pageof 10